SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-19-001621
Filing Date
2019-02-04
Accepted
2019-02-04 09:29:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G sc13g0119a4brio_markertherap.htm SC 13G/A 40973
  Complete submission text file 0001213900-19-001621.txt   42859
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-58217 | Film No.: 19561837
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570
Business Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570 516-536-0500
Brio Capital Master Fund Ltd. (Filed by) CIK: 0001560894 (see all company filings)

IRS No.: 981072321 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A